In the latest trading session, McKesson (MCK) closed at $586.08, marking a -1.1% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 0.88%. Meanwhile, the Dow ...

McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

McKesson MCK has started 2025 on a positive note, with the stock climbing 4% so far in January as investors remain optimistic ...

Evercore ISI analyst Elizabeth Anderson CFA reiterated a Buy rating on McKesson (MCK – Research Report) yesterday and set a price target of ...

Park Avenue Securities LLC lessened its position in McKesson Co. (NYSE:MCK – Free Report) by 2.5% during the fourth quarter, according to the company in its most recent filing with the Securities & ...

McKesson, which is headquartered in Irving, Texas, operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International.

AdvisorNet Financial Inc lessened its holdings in McKesson Co. (NYSE:MCK – Free Report) by 11.8% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional ...

The US Supreme Court on Tuesday signaled it would likely limit whether district courts must accept adjudications from the ...

Analysts have good reasons to be optimistic about each of the following stocks in 2025.